Global Recombinant Collagen-Based Biomaterial Market Growth 2024-2030

Publication ID:

LPI07245123

Publication Date:

July 17, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
The global Recombinant Collagen-Based Biomaterial market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淩ecombinant Collagen-Based Biomaterial Industry Forecast鈥� looks at past sales and reviews total world Recombinant Collagen-Based Biomaterial sales in 2023, providing a comprehensive analysis by region and market sector of projected Recombinant Collagen-Based Biomaterial sales for 2024 through 2030. With Recombinant Collagen-Based Biomaterial sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Collagen-Based Biomaterial industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Collagen-Based Biomaterial landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Collagen-Based Biomaterial portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Recombinant Collagen-Based Biomaterial market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Collagen-Based Biomaterial and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Collagen-Based Biomaterial.
Recombinant collagen-based biomaterials are produced through biotechnology, with advantages such as high purity, good quality consistency, and no animal pathogens, which greatly reduces the risk of immune response. This material shows broad application prospects in the fields of medicine, pharmaceuticals, cosmetics, food, and bioprinting. In medicine, recombinant collagen is used in tissue engineering and wound repair to promote tissue regeneration and healing; in the cosmetic field, it has become an important ingredient in skin care products due to its excellent moisturizing and anti-aging properties; in food and nutritional supplements, recombinant collagen provides health and beauty benefits and supports joint and skin health. In addition, recombinant collagen is used in 3D bioprinting technology to help build complex biological structures and develop tissue engineering. The versatility and safety of this material make it a key factor in promoting innovation and development in multiple industries.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Collagen-Based Biomaterial market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Medical Grade Recombinant Collagen
Cosmetic Grade Recombinant Collagen
Food Grade Recombinant Collagen
Others
Segmentation by Application:
Medical Industry
Cosmetic Industry
Food Industry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Evonik Industries
Trautec
Genemedicine
FibroGen
CollPlant
Geltor
Modern Meadow
Key Questions Addressed in this Report
What is the 10-year outlook for the global Recombinant Collagen-Based Biomaterial market?
What factors are driving Recombinant Collagen-Based Biomaterial market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Collagen-Based Biomaterial market opportunities vary by end market size?
How does Recombinant Collagen-Based Biomaterial break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Recombinant Collagen-Based Biomaterial Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Recombinant Collagen-Based Biomaterial by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Recombinant Collagen-Based Biomaterial by Country/Region, 2019, 2023 & 2030
2.2 Recombinant Collagen-Based Biomaterial Segment by Type
2.2.1 Medical Grade Recombinant Collagen
2.2.2 Cosmetic Grade Recombinant Collagen
2.2.3 Food Grade Recombinant Collagen
2.2.4 Others
2.3 Recombinant Collagen-Based Biomaterial Sales by Type
2.3.1 Global Recombinant Collagen-Based Biomaterial Sales Market Share by Type (2019-2024)
2.3.2 Global Recombinant Collagen-Based Biomaterial Revenue and Market Share by Type (2019-2024)
2.3.3 Global Recombinant Collagen-Based Biomaterial Sale Price by Type (2019-2024)
2.4 Recombinant Collagen-Based Biomaterial Segment by Application
2.4.1 Medical Industry
2.4.2 Cosmetic Industry
2.4.3 Food Industry
2.4.4 Others
2.5 Recombinant Collagen-Based Biomaterial Sales by Application
2.5.1 Global Recombinant Collagen-Based Biomaterial Sale Market Share by Application (2019-2024)
2.5.2 Global Recombinant Collagen-Based Biomaterial Revenue and Market Share by Application (2019-2024)
2.5.3 Global Recombinant Collagen-Based Biomaterial Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Recombinant Collagen-Based Biomaterial Breakdown Data by Company
3.1.1 Global Recombinant Collagen-Based Biomaterial Annual Sales by Company (2019-2024)
3.1.2 Global Recombinant Collagen-Based Biomaterial Sales Market Share by Company (2019-2024)
3.2 Global Recombinant Collagen-Based Biomaterial Annual Revenue by Company (2019-2024)
3.2.1 Global Recombinant Collagen-Based Biomaterial Revenue by Company (2019-2024)
3.2.2 Global Recombinant Collagen-Based Biomaterial Revenue Market Share by Company (2019-2024)
3.3 Global Recombinant Collagen-Based Biomaterial Sale Price by Company
3.4 Key Manufacturers Recombinant Collagen-Based Biomaterial Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Collagen-Based Biomaterial Product Location Distribution
3.4.2 Players Recombinant Collagen-Based Biomaterial Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Recombinant Collagen-Based Biomaterial by Geographic Region
4.1 World Historic Recombinant Collagen-Based Biomaterial Market Size by Geographic Region (2019-2024)
4.1.1 Global Recombinant Collagen-Based Biomaterial Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Recombinant Collagen-Based Biomaterial Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Recombinant Collagen-Based Biomaterial Market Size by Country/Region (2019-2024)
4.2.1 Global Recombinant Collagen-Based Biomaterial Annual Sales by Country/Region (2019-2024)
4.2.2 Global Recombinant Collagen-Based Biomaterial Annual Revenue by Country/Region (2019-2024)
4.3 Americas Recombinant Collagen-Based Biomaterial Sales Growth
4.4 APAC Recombinant Collagen-Based Biomaterial Sales Growth
4.5 Europe Recombinant Collagen-Based Biomaterial Sales Growth
4.6 Middle East & Africa Recombinant Collagen-Based Biomaterial Sales Growth
5 Americas
5.1 Americas Recombinant Collagen-Based Biomaterial Sales by Country
5.1.1 Americas Recombinant Collagen-Based Biomaterial Sales by Country (2019-2024)
5.1.2 Americas Recombinant Collagen-Based Biomaterial Revenue by Country (2019-2024)
5.2 Americas Recombinant Collagen-Based Biomaterial Sales by Type (2019-2024)
5.3 Americas Recombinant Collagen-Based Biomaterial Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Collagen-Based Biomaterial Sales by Region
6.1.1 APAC Recombinant Collagen-Based Biomaterial Sales by Region (2019-2024)
6.1.2 APAC Recombinant Collagen-Based Biomaterial Revenue by Region (2019-2024)
6.2 APAC Recombinant Collagen-Based Biomaterial Sales by Type (2019-2024)
6.3 APAC Recombinant Collagen-Based Biomaterial Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Recombinant Collagen-Based Biomaterial by Country
7.1.1 Europe Recombinant Collagen-Based Biomaterial Sales by Country (2019-2024)
7.1.2 Europe Recombinant Collagen-Based Biomaterial Revenue by Country (2019-2024)
7.2 Europe Recombinant Collagen-Based Biomaterial Sales by Type (2019-2024)
7.3 Europe Recombinant Collagen-Based Biomaterial Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Recombinant Collagen-Based Biomaterial by Country
8.1.1 Middle East & Africa Recombinant Collagen-Based Biomaterial Sales by Country (2019-2024)
8.1.2 Middle East & Africa Recombinant Collagen-Based Biomaterial Revenue by Country (2019-2024)
8.2 Middle East & Africa Recombinant Collagen-Based Biomaterial Sales by Type (2019-2024)
8.3 Middle East & Africa Recombinant Collagen-Based Biomaterial Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Collagen-Based Biomaterial
10.3 Manufacturing Process Analysis of Recombinant Collagen-Based Biomaterial
10.4 Industry Chain Structure of Recombinant Collagen-Based Biomaterial
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Collagen-Based Biomaterial Distributors
11.3 Recombinant Collagen-Based Biomaterial Customer
12 World Forecast Review for Recombinant Collagen-Based Biomaterial by Geographic Region
12.1 Global Recombinant Collagen-Based Biomaterial Market Size Forecast by Region
12.1.1 Global Recombinant Collagen-Based Biomaterial Forecast by Region (2025-2030)
12.1.2 Global Recombinant Collagen-Based Biomaterial Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Recombinant Collagen-Based Biomaterial Forecast by Type (2025-2030)
12.7 Global Recombinant Collagen-Based Biomaterial Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Evonik Industries
13.1.1 Evonik Industries Company Information
13.1.2 Evonik Industries Recombinant Collagen-Based Biomaterial Product Portfolios and Specifications
13.1.3 Evonik Industries Recombinant Collagen-Based Biomaterial Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Evonik Industries Main Business Overview
13.1.5 Evonik Industries Latest Developments
13.2 Trautec
13.2.1 Trautec Company Information
13.2.2 Trautec Recombinant Collagen-Based Biomaterial Product Portfolios and Specifications
13.2.3 Trautec Recombinant Collagen-Based Biomaterial Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Trautec Main Business Overview
13.2.5 Trautec Latest Developments
13.3 Genemedicine
13.3.1 Genemedicine Company Information
13.3.2 Genemedicine Recombinant Collagen-Based Biomaterial Product Portfolios and Specifications
13.3.3 Genemedicine Recombinant Collagen-Based Biomaterial Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Genemedicine Main Business Overview
13.3.5 Genemedicine Latest Developments
13.4 FibroGen
13.4.1 FibroGen Company Information
13.4.2 FibroGen Recombinant Collagen-Based Biomaterial Product Portfolios and Specifications
13.4.3 FibroGen Recombinant Collagen-Based Biomaterial Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 FibroGen Main Business Overview
13.4.5 FibroGen Latest Developments
13.5 CollPlant
13.5.1 CollPlant Company Information
13.5.2 CollPlant Recombinant Collagen-Based Biomaterial Product Portfolios and Specifications
13.5.3 CollPlant Recombinant Collagen-Based Biomaterial Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CollPlant Main Business Overview
13.5.5 CollPlant Latest Developments
13.6 Geltor
13.6.1 Geltor Company Information
13.6.2 Geltor Recombinant Collagen-Based Biomaterial Product Portfolios and Specifications
13.6.3 Geltor Recombinant Collagen-Based Biomaterial Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Geltor Main Business Overview
13.6.5 Geltor Latest Developments
13.7 Modern Meadow
13.7.1 Modern Meadow Company Information
13.7.2 Modern Meadow Recombinant Collagen-Based Biomaterial Product Portfolios and Specifications
13.7.3 Modern Meadow Recombinant Collagen-Based Biomaterial Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Modern Meadow Main Business Overview
13.7.5 Modern Meadow Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂